However, because receptors of the D2 subfamily are found in both limbic and striatal regions, their blockade results respectively in both the desired reduction in psychosis and the unwanted appearance of Parkinson-like adverse effects. Blockade of D2 receptors which inhibit prolactin release results in increased plasma prolactin concentrations.